Question · asked by 1 review

Immunologic response to YF vaccine in HIV‐infected adults vs immunologic response to YF vaccine: Duration: Adequate antibody response (NT ≥1:10),

Population
adults with HIV infection
Intervention
Immunologic response to YF vaccine in HIV‐infected adults
Comparison
immunologic response to YF vaccine
Outcome
Duration: Adequate antibody response (NT ≥1:10),

It is very uncertain whether immunologic response to YF vaccine in HIV‐infected adults changes duration: Adequate antibody response (NT ≥1:10), compared with immunologic response to YF vaccine (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Immunologic response to YF vaccine in HIV‐infected adults vs immunologic response to YF vaccine
Duration: Adequate antibody response (NT ≥1:10), · Adults with HIV infection
It is very uncertain whether immunologic response to YF vaccine in HIV‐infected adults changes duration: Adequate antibody response (NT ≥1:10), compared with immunologic response to YF vaccine (very low certainty).
Yellow fever vaccine for patients with HIV infection (2014) · Cochrane Headline outcomes only
RR 0.88 [0.76, 1.02]1 study · 162 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Yellow fever vaccine for patients with HIV infection
2014 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.